Gypsy Basin Genomics
Latest round
- Seed
Last raised
- Feb 2021
Total raised
- Undisclosed
Investors
- 2
About Gypsy Basin Genomics
Founded in 2018 in New York, US, Gypsy Basin Genomics, Inc. focuses on genomic solutions aimed at improving healthcare. The company was established by Joseph Sullivan.Gypsy Basin Genomics specializes in advanced genomic sequencing and analysis solutions designed to enhance healthcare outcomes and personalized medicine. Their core offerings include a suite of genomic diagnostic tools that enable clinicians and researchers to identify genetic predispositions to various diseases and tailor treatment plans accordingly. The services focus on areas such as oncology, rare genetic disorders, and precision medicine, facilitating early detection and effective intervention strategies. Their clientele includes hospitals, research institutions, and biotech companies across North America and Europe, where the demand for personalized healthcare solutions is rapidly growing.Gypsy Basin Genomics operates on a business-to-business (B2B) model, providing subscription-based services and partnerships with healthcare providers and research institutions. Revenue is generated primarily through the sale of their genomic diagnostic tools and subscription plans that offer data analysis and ongoing support. Healthcare institutions may enter into annual contracts that include a set number of sequencing tests and analysis reports, tailored to their specific needs. The pricing structure reflects the complexity and volume of services provided, with flagship products commanding premium pricing.Gypsy Basin Genomics aims to expand its product line with new genomic diagnostic tools expected to launch in late 2023, targeting enhanced analytics for oncology and rare disorders. The company plans to enter the European market by 2024 to meet growing demand for personalized healthcare solutions.
Who invested in Gypsy Basin Genomics
2 investors across 1 round
See all investors in Gypsy Basin Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Feb 16, 2021
Amount
Undisclosed
Investors
Questions about Gypsy Basin Genomics
Who invested in Gypsy Basin Genomics?
Gypsy Basin Genomics has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Gypsy Basin Genomics raised?
Gypsy Basin Genomics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Gypsy Basin Genomics last raise money?
Gypsy Basin Genomics's most recent round on record is a Seed, in Feb 2021.
What does Gypsy Basin Genomics do?
Founded in 2018 in New York, US, Gypsy Basin Genomics, Inc.
Where is Gypsy Basin Genomics headquartered?
Gypsy Basin Genomics is headquartered in New York, US.
Which VCs invest in companies like Gypsy Basin Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Gypsy Basin Genomics's stage. Their profiles are linked below.
VCs backing healthcare startups at Seed
Raising like Gypsy Basin Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.